Navigation Links
NCPA Statement in Response to President Bush's FY 2009 Budget Proposal
Date:2/4/2008

ALEXANDRIA, Va., Feb. 4 /PRNewswire-USNewswire/ --- President George W. Bush today submitted his budget proposal to Congress for fiscal year 2009. In response Bruce Roberts, RPh, executive vice president and CEO of the National Community Pharmacists Association (NCPA) issued the following statement:

"President Bush's efforts to rein in government spending places a dangerous target on health care, and even more specifically the Medicare and Medicaid programs. While fiscal restraint is important and necessary, programs to support this nation's elderly and impoverished should be preserved, especially in the area of Medicaid generic prescription drug reimbursements.

"A patient's medical needs don't diminish just because their community pharmacy is threatened. In underserved rural and urban communities these patients lack options other than expensive emergency rooms and doctors' offices. The proposed savings are fictional. If adopted, the health care costs would actually rise because community pharmacies would not be there for their patients.

"We urge Congress to reject, as it has the last two years, this ill-advised gutting of Medicaid. We also hope the Democrat and Republican nominees for President will make sure to include policies in their health care proposals that do not hurt the small business, community pharmacy owners that so ably serve their patients on the front lines of America's health care system."

BACKGROUND:

For the third year in a row President Bush has sought to limit the Federal Upper Limit (FUL) pharmacies receive for participating in this program that provides economically disadvantaged Americans with their medication needs. The number has been reduced from 250% to 150% of Average Manufacturer price (AMP). This reduction significantly limits the ability of small business owners to serve their communities and patients. The Government Accountability Office has already calculated that a FUL reimb
'/>"/>

SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. NCPA Statement on White House Campaign to End Teenage Prescription Drug Abuse
2. Statement of the American Diabetes Association on the Administrations Proposal to Undermine Funds for Research, Prevention and Treatment in FY09
3. NutraCea Files Universal Shelf Registration Statement
4. AAFP Statement - Family Physicians to President Bush: Call for Improved Health Access is Only One Step to Comprehensive Reform
5. Statement by AARP CEO Bill Novelli on President Bushs State of the Union
6. Statement of Robert K. Ross, M.D.
7. NCPA Statement on Wal-Marts Entry Into the Pharmacy Benefit Market
8. Accuro Healthcare Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering
9. Statement by Bruce Bodaken on Senate Health Committee Action
10. AASM statement on use of sleep medications
11. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...Ind., Aug. 29 /PRNewswire/ -- Conseco Insurance Co...announced the availability of its new,indexed uni... The policy,provides upside potential with downsid...niversal life policy that offers the,opportunity f...m index,credit of 1%. Clients can customize their ...
(Date:8/29/2008)...Va., Aug. 29 /PRNewswire-USNewswire/ -- The Custom...d today the launch of the Endocrine,Daily Briefing...tigious,Endocrine Society., Endocrine Daily Brief...0 Endocrine Society members, medical professionals...betes and osteoporosis. Endocrine Daily,Briefing j...
(Date:8/29/2008)...ates disappointed that Obama failed to address the...- Speaking at the Democratic,National Convention W...ed,for a reinvigorated response to the domestic HI...Presidential nominee Barack Obama, Clinton said,"...ble global leadership in,an area in which I am dee...
(Date:8/29/2008)...ON, Aug. 29 /PRNewswire-USNewswire/ -- The followi...Campaign for Tobacco-Free Kids:, For the second t...d to,withdraw sponsorship and promotion of a conce...rnational criticism for engaging in cigarette,mark...p Morris International has been forced to withdraw...
Breaking Medicine News(10 mins):Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Custom Briefings Announces Launch of Endocrine Daily Briefing 2Health News:Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention 2Health News:Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention 3Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2
...s suffering from tennis elbow ask them to alter th....// A new study evaluating the muscle firing patte... no bearing on the development of tendonitis. Res...p" on the relationship between the development of ...
...has made public its plan of enforcing a ban on smo...ices, cinemas, factories, pubs, bars and such othe... ban.// But the ban does not include outdoors or p...s in England will be required to put up visible “N...
...ey 2005-06 has revealed the extent of spousal viol... injustice meted out to unmarried women. The surve... f 30 organizations who were involved in accumulat...ment in certain categories. Fred Arnold, Vice-Pres...
... needed, especially into the possible genetic and ... in Bhopal exactly// 22 years ago that killed more... subsequent years. Despite the neurological, horm...he survivors are facing besides the genetic damage...
Other Medicine News:Health News:Tennis Elbow is Not Caused Due to Improperly Sized Tennis Racket Grip 2Health News:Tennis Elbow is Not Caused Due to Improperly Sized Tennis Racket Grip 3Health News:Children of Bhopal Gas Victims Suffer from Deformity 2Health News:Children of Bhopal Gas Victims Suffer from Deformity 3
(Date:8/26/2008)...wswire/ -- Semafore Pharmaceuticals Inc.,presented...geted Therapies,in Cancer in Washington, D.C., ann...se inhibitors that demonstrate significant antican... proprietary molecular scaffold has been developed...ign of pan-PI3 kinase inhibitors,as well as isofor...
(Date:8/26/2008)...nnovative Manufacturing - Has Potential to ..., ROCKVILLE, Md., Aug. 26 /PRNewswire-FirstCall/ ...favorable results from the second stage of,the Pha...uenza virus-like,particle (VLP) vaccine candidate....induced robust neutralizing antibody responses. No...
(Date:8/25/2008)... calls it a ,miracle, LATHAM, N.Y., Aug. 25 /PRN...ided Radiation Therapy program at Community Care P... patients using RapidArc(TM),radiotherapy technolo...dvancement that delivers a highly-precise image-gu...tment in two minutes or less., RapidArc treatment...
(Date:8/22/2008)...Newswire-FirstCall/ -- Human Genome,Sciences, Inc....leted the,enrollment and initial dosing of patient...umumab) in combination with the chemotherapy agent... in advanced non-small cell,lung cancer (NSCLC)., ...416/HGSLOGO ), "There is an urgent medical need ...
Breaking Medicine Technology:Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti Aging Applications 1501 1National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti Aging Applications 1501 2Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 1Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 2Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 3Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 4Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 5Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine 28MSI 1436 29 Data from the North American Association for the Study of Obe 658 6Scientists discover tiny RNAs play a big role in controlling genes 4578 1Public not so sure personalized medicine 4574 1Public not so sure personalized medicine 4574 2
...serex Tango ophthalmic laser system provides two l...isruptor for posterior capsulotomy and iridotomy. ...ing pulsed 532 nm light. The photodisruptor laser ...ser can be easily selected and treatment by both l...
Thin and smooth jaws, designed to enter trough 3 mm incision, cross action.
Flat handle.
Angled shafts, smooth jaws, polished finish.
Medicine Products: